Genadyne Biotechnologies Awarded GPO Contract by The MED Group

    GREAT NECK, NY, September 14, 2010 /24-7PressRelease/ -- Genadyne Biotechnologies, a US based developer and manufacturer of negative pressure wound therapy systems, non-powered and powered pressure relieving therapeutic surfaces, and The MED Group, a Group Purchasing, Business Solutions and Referral Management Network, has agreed on a Group Purchasing Agreement whereby Genadyne would be able to offer their Negative Pressure Wound Therapy systems to the MED members - Home Care Providers (more than 365 market leaders covering 1,000+ locations).

"On behalf of Genadyne, I am very excited about our new partnership with The MED Group and we look forward to working with its Members and identifying new ways to diversify their product offering," said Chien-Ming GOH (Andrew) Genadyne, V.P. of Operations.

MED Group

The MED Group is a Group Purchasing, Business Solutions and Referral Management Network that helps Home Care Providers (more than 365 market leaders covering 1,000+ locations) lower their purchasing costs for home medical equipment, health care, technology and other supplies-- from cell phones to office supplies and everything in between.

MED also helps its Provider members increase patient referral revenue and improve efficiencies in education and training, reimbursement, accreditation, certification, logistics and other operational areas.

Through partnerships with the best industry consultants, other organizations and its own resources, MED connects partners and delivers results to create value for its Customers: Providers, Supply Partners and Payers.
MED is celebrating its 40th year of service.

Genadyne

Genadyne Biotechnologies Inc. is a US based developer and manufacturer of negative pressure wound therapy systems, non-powered and powered pressure relieving therapeutic surfaces, wireless telemedicine solutions, wireless and wired weight scale systems and more.

The mission of Genadyne is to promote wound healing, decrease wound recurrence and maintain the dignity, independence, comfort and pain control of the wound care patient through our products and through education.

Chien-Ming (Andrew) GOH

Andrew has been with Genadyne Biotechnologies since 2005. He has been influential in developing a wide array of wound care products, most notably the Negative Pressure Wound Therapy Systems (Genadyne XLR8 and Genadyne A4), as well as several wireless telemetry software solutions and more.

Andrew currently holds a MBA in Finance from City University of New York - Baruch College and has a Bachelors of Science in Electrical Engineering from the State University of Buffalo.

Genadyne Biotechnologies is a US based manufacturer of specialty and advance wound care products. For more information about Genadyne, please visit us at our website at www.genadyne.com.

# # #